Sanofi-Aventis finally threw in the towel on its troubled anti-obesity pill Acomplia on Wednesday by announcing it would discontinue all clinical trials involving the drug.
The decision comes after European health authorities last month said Acomplia should be withdrawn from sale over links to mental disorders. The drug already faced a bleak future after it failed to win U.S. marketing approval in 2007.
"Today's company decision has been taken in light of recent demands by certain national health authorities. As a result the feasibility of the global clinical development programme has been compromised," Sanofi said in a statement.
More at Reuters
No comments:
Post a Comment